Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

CTT Pharma Signs Agreement for New Oral Products

CTTH

(TheNewswire)

CTT Pharmaceutical Holdings Inc

Tampa, Florida, United States - The Newswire - November 22, 2022 - CTT Pharmaceutical Holdings, Inc (OTC:CTTH) has signed a definitive agreement using our technology to make 3 oral products that will include chewing gum, gummies, and pills as prototypes. CTT has also verbally committed to doing additional oral products upon the successful completion of the first 3 products.

CTT will notify shareholders once product development starts and will keep shareholders updated on the progression of these products, which will include testing for stability and efficacy. Ryan Khouri, CEO of CTT Pharma stated, While our dissolvable strips will be the fastest way to deliver APIs, having the ability to create other fast oral products could create more opportunities for CTT.

www.cttpharmaceuticals.com

www.linkedin.com/in/ryan-khouri-679a251b7

CTT Pharma – 813-606-0060

Copyright (c) 2022 TheNewswire - All rights reserved.